Hints and tips:
Related Special Reports
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...Additional help by Michela Tindera, Cara Shillenn, Sam Giovinco, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Our engineer is Monica Lopez....
...The European Union plans to hit Apple with a €500mn fine over music streaming, German companies make record investments in the US, and emerging market investors switch to ETFs that exclude China....
...Last week the company criticised Brazilian judges’ orders for it to censor “certain popular accounts”....
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
...But, of course, there’s a reason why it’s widely called Shitibank; the sprawling, gormless Citi has for a v v v very long time proven adept at blithely ambling onto various rakes around the world....
...Merck’s drug raised fresh hopes and sent shares in the company rallying late last year after early data from a late-stage trial suggested that it cut in half the risk of death and hospitalisation....
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...Merck’s lawsuit is the first by a major drug company, but analysts predict others are likely to follow its lead and sue the government ahead of the full implementation of the drug price negotiation elements...
...Yet Merck recorded sales worth more than $6bn between 2021 and 2022, and the figure does not include sales in poorer markets where licensed companies make generic versions of the drug....
...Yet the company’s monoclonal antibody treatment for inflammatory bowel disease has yet to be fully approved....
...Its companies have combined annual revenues of $75bn and 115,000 employees....
...Merck said the deal would strengthen the company’s position in the fast-growing field of immunology, where there is significant unmet patient need....
...the crisp company....
...Companies became quite conservative and cautious....
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
...Implementing the proposals could undermine the company’s core business model, said Merck in response to a proposal made by The Capuchin Franciscan Province of St. Joseph....
...She is the company’s first outsider and first female CEO, one of only 52 women leading Fortune 500 companies....
...The US Supreme Court rules to protect big tech companies from being liable for users’ posts, and G7 countries are preparing new sanctions against Russia....
...The Federal Trade Commission sued to block the biotechnology company Amgen’s $28.3bn deal to acquire Horizon Therapeutics, Italy is struggling to spend €200bn in EU Covid recovery funds, and Ukraine said...
...Merck was in talks last summer to acquire Seagen for about $200 a share, or $40bn. But negotiations ended after the two failed to agree on price....
...Dean Li, president of Merck Research Laboratories, said the positive trial findings represented an important milestone in the company’s collaboration with Moderna....
...Francisco Daniel Da Silva South African. Hult International Business School, graduated 2023....
...Merck had been in talks to acquire Seagen last summer, offering about $200 a share, according to people familiar with the matter....
International Edition